Pharmacotherapy:

More Info
Jack Bergman, PhD

Associate Professor of Psychobiology in the Department of Psychiatry, HMS

Behavioral Pharmacology Program

Mechanisms of substance abuse, abuse-related effects of stimulants, abuse liability of novel anxiolytics

More Info
J. Alexander Bodkin, MD

Director, Clinical Psychopharmacology Research Program, McLean Hospital
Assistant Professor of Psychiatry, Harvard Medical School

Clinical Psychopharmacology Research Program

Clinical trials in depression, anxiety, and insomnia; measurement of mood and cognition

More Info
Bruce Cohen, M.D., Ph.D.

Robertson-Steele Professor of Psychiatry, HMS; Psychiatrist and Director of the Program for Neuropsychiatric Research

Shervert H. Frazier Research Institute

Molecular, cellular, animal models of mood and psychotic disorders

More Info
Hilary Smith Connery, MD, PhD

Clinical Director, Alcohol and Drug Abuse Treatment Program; Assistant Professor of Psychiatry

Alcohol and Drug Abuse Treatment Center

novel treatments for opioid dependence and co-morbid psychiatric and substance-use disorders

More Info
Maurizio Fava, MD

Senior Mentor

Director, Depression Clinical and Research Program, MGH
Slater Family Professor of Psychiatry, HMS
Executive Vice Chair, Department of Psychiatry, MGH
Executive Director, Clinical Trials Network and Institute, MGH

Depression Clinical & Research Program

Neuropsychopharmacology

More Info
Brent Forester, MD, PhD

Chief, Division of Geriatric Psychiatry, McLean Hospital
Director, Geriatric Mood Disorders Research Program, McLean Hospital
Site Director, HMS Psychiatry Core Clerkship, McLean Hospital
Assistant Professor of Psychiatry, Harvard Medical School
Medical Director, Behavioral Health in Population Health Management, Partners Healthcare

Geriatric Psychiatry Research Program

predictors and moderators of treatment response in older adults with bipolar disorder and depression using brain imaging and neuropsychological evaluation

More Info
Randy Gollub, MD, PhD

Associate Director, Psychiatric Neuroimaging Research Program, MGH
Assistant in Neuroscience, Radiology, MGH
Associate Professor of Psychiatry, Harvard Medical School

Athinoula A. Martinos Center for Biomedical Imaging

human imaging approaches to studies of pain perception including the effects of expectancy, placebo and verum acupuncture analgesia, as well as the development of an infrastructure to enable the secondary research use of clinical data and medical images through the application of clinical neuroimaging informatics.

More Info
Shelly Greenfield, MD, MPH

Chief Academic Officer, McLean Hospital
Chief, Division of Women’s Mental Health, McLean Hospital
Director, Alcohol and Drug Abuse Clinical and Health Services Research Program, McLean Hospital
Professor of Psychiatry, Harvard Medical School

Alcohol and Drug Abuse Treatment Program

Development of new treatments for patients with substance use disorders and innovating the integration of delivery of mental health and substance abuse treatment services into diverse settings

More Info
David Henderson, MD

Director, Schizophrenia Diabetes and Weight Reduction Research, MGH
Director, Chester M. Pierce M.D. Division of Global Psychiatry, MGH
Adjunct Professor of Epidemiology, Harvard T.H. Chan School of Public Health

Global Psychiatry
MGH Schizophrenia Program

psychopharmacological and antipsychotic agents in the treatment of schizophrenia, impacts of antipsychotic agents on metabolic anomalies and glucose metabolism, and ethnic and cultural impacts on psychiatry

More Info
James Hudson, MD, ScD, SM

Director, Biological Psychiatry Laboratory, McLean Hospital
Professor of Psychiatry, Harvard Medical School

Biological Psychiatry Laboratory

Alcohol and Drug Abuse Clinical Research Center

genetic epidemiology of eating disorders, mood disorders, fibromyalgia, personality disorders, and substance use disorders. Pharmacologic treatment studies for psychiatric disorders and pain syndromes.

More Info
Haiden A. Huskamp, PhD

Henry J. Kaiser Professor of Health Care Policy, Department of Health Care Policy, Harvard Medical School

Blavatnik Institute: Health Care Policy

More Info
David Mischoulon, MD, PhD

Director of Research, Depression Clinical and Research Program, MGH; Associate Professor of Psychiatry, HMS

Depression Clinical & Research Program

clinical trials for depression, including medications and psychotherapy; complementary and alternative medicines

More Info
J. Michael Murphy, EdD

Associate Professor of Psychology

survey research in outpatient pediatric, mental health, and educational settings

More Info
Andrew Nierenberg, MD

Thomas P. Hackett, MD, Endowed Chair in Psychiatry, MGH
Director, Bipolar Clinic and Research Program, MGH
Associate Director, Depression Clinical and Research Program, MGH
Director, Clinical Research Support Office, Clinical Research Program, MGH
Professor of Psychiatry, Harvard Medical School

Dauten Family Center for Bipolar Treatment Innovation

Clinical trials in mood disorders, non-linear dynamic modeling

More Info
Roy Perlis, MD, MSc

Director, Psychiatry Center for Experimental Drugs and Diagnostics, MGH
Associate Director, Psychiatric Genetics Program in Mood and Anxiety Disorders, MGH
Associate Professor of Psychiatry, Harvard Medical School

MGH Psychiatry Center for Quantitative Health

Patient-derived cellular models of disease using induced pluripotent stem cells; pharmacogenomics and clinical risk stratification; proof-of-concept/first-in-human clinical trials

More Info
Diego Pizzagalli, PhD

Director, Center for Depression, Anxiety and Stress Research, McLean Hospital
Director, McLean Imaging Center
Director, Laboratory for Translational and Affective Neuroscience
Professor of Psychiatry, Harvard Medical School

Laboratory for Affective and Translational Neuroscience

Behavioral, electrophysiological, and neuroimaging approaches to investigate cognitive and affective dysfunction in depression and anxiety disorders; improve our understanding the pathophysiology of these disorders; and develop biomarkers of treatment response.

More Info
Harrison W. Pope, MD

Pyschiatrist & Director, Biological Psychiatry Laboratory, McLean; Professor of Psychiatry, HMS

Biological Psychiatry Laboratory

eating disorders, mood disorders, anabolic-androgenic steroid abuse, and psychopharmacological treatment effectiveness.

More Info
Jerrold F. Rosenbaum, MD

Chief of Psychiatry, MGH
President & Executive Director, Mood and Anxiety Disorders Institute (MADI), MGH
Stanley Cobb Professor of Psychiatry, Harvard Medical School

Mood and Anxiety Disorders Institute (MADI)

treatment resistant depression, anxiety disorders, genetic and temperamental links to anxiety and mood disorders

Elizabeth T. Ryan, PhD

Director, Sleep Diagnostics and Treatment Laboratory, McLean Hospital
Associate Director, Behavioral Psychopharmacology Research Laboratory, McLean Hospital
Instructor in Psychiatry, Harvard Medical School

Research Gate Profile

More Info
Jordan Smoller, M.D., Sc.D.

Broad/MGH, Dept. of Psychiatry

Professor of Psychiatry, HMS; Professor, Department of Epidemiology, Harvard School of Public Health; Associate Chief for Research, Department of Psychiatry, MGH; Director, Psychiatric Genetics, MGH; Director, Psychiatric and Neurodevelopmental Genetics Unit (PNGU), MGH; Co-Director, Genetics and Genomics Unit Clinical Research Program, MGH; Associate Member, Broad Institute; Senior Scientist, Stanley Center for Psychiatric Research, Broad/MIT

Psychiatric and Neurodevelopmental Genetics Unit

psychiatric and genetic epidemiology, clinical psychiatric research, statistical genetics, linage and association studies, imaging genetics, and pharmacogenetics. Design and conduct of psychiatric genetic studies, including studies of behavioral and neuroimaging intermediate phenotypes.

More Info
Roger Weiss, MD

Chief, Division of Alcohol and Drug Abuse, McLean Hospital
Director, Alcohol and Drug Abuse Clinical Research Program, McLean Hospital
Professor of Psychiatry, Harvard Medical School

Alcohol and Drug Abuse Treatment Program

Alcohol and drug abuse research

More Info
Sabine Wilhelm, PhD

Chief of Psychology, MGH; Director of the OCD and Related Disorders Program, MGH; Professor of Psychology, Department of Psychiatry, HMS

Tic Disorders Clinic and Research Unit

CBT and pharmacotherapy for OCD and related disorders (including body dysmorphic disorder and Tourette’s disorder)

More Info
Janet Wozniak, MD

Director, Quality and Safety, Department of Psychiatry, MGH; Director, Child and Adolescent Outpatient Service, MGH; Director, Pediatric Bipolar Disorder Clinical and Research Program, MGH; Associate Professor of Psychiatry

Pediatric Psychopharmacology Clinical & Research Program

emotional dysregulation in youth with bipolar disorder, autism spectrum disorder and ADHD

More Info
Mary Zanarini, EdD

Program Director, Laboratory for the Study of Adult Development, McLean Hospital
Professor of Psychology, Harvard Medical School

McLean Center for the Treatment of Borderline Personality Disorder

Etiology, phenomenology, co-occurring disorders, treatment response, and long-term course of borderline personality disorder.a